ST葫芦娃：子公司广西维威制药有限公司获得复方聚乙二醇（3350）电解质口服溶液药品注册证书

Core Viewpoint - The company ST HuLuWa has received approval from the National Medical Products Administration for its subsidiary Guangxi Weiwei Pharmaceutical Co., Ltd. to market a new oral solution for chronic constipation and fecal impaction, enhancing its product line [1] Group 1 - The approved drug is a compound polyethylene glycol (3350) electrolyte oral solution, developed by Norgine, and contains active ingredients such as polyethylene glycol 3350, sodium chloride, potassium chloride, and sodium bicarbonate [1] - The company has invested a total of RMB 762,100 in research and development for this drug [1] - The approval of the drug registration certificate will further enrich the company's product offerings [1]